An olive polyphenol-based nutraceutical improves cutaneous manifestations of psoriasis in humans
Authors:
- E. Herrera AcostaEAE. Herrera Acosta
- J. Alonso Suárez PérezJPJ. Alonso Suárez Pérez
- J. Aguilera ArjonaJAJ. Aguilera Arjona
- F. VisioliF. Visioli
- 1 December 2016
- journal article
- Published by Elsevier in PharmaNutrition
- Vol. 4 (4) , 151-153
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Redox homeostasis: The Golden Mean of healthy livingRedox Biology, 2016
- Psoriasis Trends and Practice GapsDermatologic Clinics, 2016
- PsoriasisClinics in Podiatric Medicine and Surgery, 2016
- The Redox CodeAntioxidants & Redox Signaling, 2015
- One-week administration of hydroxytyrosol to humans does not activate Phase II enzymesPharmacological Research, 2015
- Xenobiotics and human health: A new view of their pharma-nutritional rolePharmaNutrition, 2015
- Enough Is Enough: Stop Wasting Money on Vitamin and Mineral SupplementsAnnals of Internal Medicine, 2013
- Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapyRedox Report, 2013
- Polyphenols and health: Moving beyond antioxidantsJournal of Berry Research, 2012
- Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cholesterol concentrations (ID 1639), mainteEFSA Journal, 2011